Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4

Authors: Zhangyuan Gu, Fugui Ye, Hong Luo, Xiaoguang Li, Yue Gong, Shiqi Mao, Xiaoqing Jia, Xiangchen Han, Boyue Han, Yun Fu, Xiaolin Cheng, Jiejing Li, Zhiming Shao, Peizhen Wen, Xin Hu, Zhigang Zhuang

Published: 2025-03-17

DOI: 10.1186/s12929-025-01129-7

Source: Full article


Abstract

Abstract